Stock IRON DISC MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Disc Medicine, Inc.

Equities

IRON

US2546041011

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
46.62 USD +4.93% Intraday chart for Disc Medicine, Inc. +3.44% -19.29%
Jun. 20 Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing MT
Jun. 17 BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Disc Medicine Prices $178 Million Common Stock Offering; Shares Rise
MT
Disc Medicine, Inc. Presents Positive Clinical Data Across Portfolio At the European Hematology Association 2024 Congress
CI
Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Stocks Seen -2-
DJ
Disc Medicine Trial of Light Sensitivity Treatment Achieves Primary Goal, But Misses Secondary Endpoint; Wedbush Cuts Price Target -- Shares Plunge
MT
Disc Medicine, Inc. Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Porphyria
CI
Disc Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Disc Medicine Says FDA Grants Fast Track Designation for Investigational Treatment of Chronic Kidney Disease, Anemia
MT
Disc Medicine Inc Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
CI
Disc Medicine Says Potential Blood Disease Treatment Gets FDA Orphan Drug Designation
MT
Disc Medicine Gets Orphan Drug Designation for Blood-Disorder Treatment
DJ
Disc Medicine, Inc. Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
CI
North American Morning Briefing : S&P 500 Futures -2-
DJ
Disc Presents Initial Positive Data from Ongoing Phase 1B/2 Trial of Disc-0974 in Patients with Myelofibrosis (Mf) and Anemia At the 65Th American Society of Hematology Annual Meeting
CI
Disc Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Disc Medicine, Inc. Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
CI
Arix Bioscience boosts net value, CEO jumping ship for PureTech Health
AN
Disc Medicine Gets FDA Fast Track Designation for MWTX-003 in Polycythemia Vera Treatment
MT
Disc Medicine Opco Inc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IRON Stock
  4. News Disc Medicine, Inc.
  5. Highlights